PhD. Paweł Wańkowicz Neurologist/Neuroimmunologist
Doctor Wańkowicz is a neurologist, neuroimmunologist and clinician all in one. He is also an Assistant Professor and the author, editor, and reviewer of numerous scientific publications in respected national and international journals. In addition, he runs a regular column in the Polish Neurological Review.
He is a member of the Polish Neurological Society, the European Society of Systemic Lupus Erythematosus, and the International Encephalitis Society. Since 2021, he has held the position of a member of the Scientific Council of Pomeranian Medical University in Szczecin, Poland.
He also coordinates the implementation of scientific research within interdisciplinary research teams in Poland and abroad. The results of this collaboration are three current research topics and a project within Innovation Incubator 2.0.
Research Topics
- Primary prevention of ischemic stroke associated with atrial fibrillation– is oral anticoagulant therapy sufficient?
The following scientific articles have been written based on the research conducted within the framework of this research with his leading participation:
- Wańkowicz P., et al. Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range. Arch Med Sci. 2019 Sep;15(5):1217-1222.
- Wańkowicz P., et al. Atrial fibrillation risk factors in patients with ischemic stroke. Archives of Medical Science. 2021;17(1):19-24.
- Wańkowicz, P., et al. Ischemic Stroke Risk Factors in Patients with Atrial Fibrillation Treated with New Oral Anticoagulants. J. Clin. Med. 2021, 10, 1223.
- Wańkowicz P., et al. Pre-Stroke Statin Therapy Improves In- Hospital Prognosis Following Acute Ischemic Stroke Associated with Well-Controlled Nonvalvular Atrial Fibrillation. J Clin Med. 2021;10(14):3036.
- Research on neuropsychiatric disorders in systemic lupus erythematosus
This research has become the subject of the following publications:
- Wańkowicz P., et al. Clinical manifestations of neuropsychiatric systemic lupus erythematosus: a single-center study from West Pomerania Province in Poland. Pol Arch Intern Med. 2020;130(1):82-84.
- Wańkowicz P., et al. An overlapping case of Bickerstaff brainstem encephalitis and acute motor axonal neuropathy variant of Guillain-Barré syndrome associated with systemic lupus erythematosus. Pol Arch Intern Med. 2019, Jan 31;129(1):50-51.
- This publication is based on the case of a young patient with a diagnosis of systemic lupus erythematosus, who was additionally diagnosed by Dr. Wańkowicz with a syndrome of overlapping Bickerstaff’s truncus inflammation and acute axonal motor neuropathy, which is a variant of Guillain-Barre syndrome. Prior to receiving care, the patient’s general and neurological condition had steadily deteriorated. After the above variant was diagnosed and appropriate treatment was administered, the patient’s general and neurological condition improved from week to week.
- Mental health in the era of the COVID-19 pandemic
Current research in the era of COVID-19 deals only marginally with the role of autoimmune diseases as a major trigger or exacerbator of mental disorders or insomnia during the COVID-19 pandemic. Three of the current studies relating to this issue were conducted by Dr. Paweł Wańkowicz’s team. They were the basis for the following publications:
- Wańkowicz, P., et al. Assessment of Mental Health Factors among Health Professionals Depending on Their Contact with COVID-19 Patients. Int. J. Environ. Res. Public Health 2020, 17, 5849.
- Wańkowicz, P., et al. Evaluation of Mental Health Factors among People with Systemic Lupus Erythematosus during the SARS-CoV-2 Pandemic. J.Clin. Med. 2020, 9, 2872.
- Wańkowicz, P., et al. The Impact of the COVID-19 Pandemic on Psychological Health and Insomnia among People with Chronic Diseases. J. Clin. Med. 2021, 10, 1206.
- Wańkowicz, P., et al. Insomnia, Anxiety, and Depression Symptoms during the COVID-19 Pandemic May Depend on the Pre-Existent Health Status Rather than the Profession. Brain Sci. 2021, 11, 1001.
Innovation Incubator 2.0 Project
Creating a test for the neuropsychiatric form of systemic lupus erythematosus. Can we predict the future?
Given Dr. Paweł Wańkowicz’s long-standing observation of patients with autoimmune diseases, in 2017-2018 he conducted an interdisciplinary pilot study to compare the concentration of factors that influenced neuroimmune response in patients with the neuropsychiatric form of systemic lupus erythematosus and healthy volunteers. The study results became the basis for the winning of a grant in the Innovation Incubator 2.0 competition in 2019. The project is currently in the commercialization phase.
The implementation of the Innovation Incubator 2.0 project has paid off through expanded international collaborations. Since 2018, Dr. Paweł Wańkowicz has been collaborating with the Universidad Catolica San Antonio de Murcia in Spain in the field of autoimmune disease research, and, in particular, in the study of the neuropsychiatric form of systemic lupus erythematosus.
Marcin Narloch
FutureBrain attorney, legal counsel, and graduate of the law faculty at Europa Universität „Viadrina” in Frankfurt (Oder), Germany, and Adam Mickiewicz University in Poznań, Poland.
Marcin Narloch has expanded his knowledge in the field of European and International Business Law at Ludwig-Maximilian-Universität in Munich, Germany, where he obtained the title LL.M. Eur. (Master of European and International Business Law).
He has been successfully advising foreign and Polish companies in establishing, organizing, conducting, and developing business activities in Poland for more than 19 years. He supports his clients with his knowledge, extensive experience, creative ideas, and innovative legal solutions.
In 2015, he became the managing partner of a law firm, where he provided his services as a legal advisor.